在美国推进瘤药物开发:创新与监管科学之间的相互作用
1Oncology Regulatory Science, Strategy & Excellence, AstraZeneca, Gaithersburg, MD, USA. yannandou@gmail.com.
Therapeutic innovation & regulatory science
|May 22, 2025
概括
癌症药物开发方面的创新正在迅速推进. 监管科学适应新技术,确保安全,并通过合作加速患者获得新疗法.
科学领域:
- 在瘤学瘤学.
- 监管科学 监管科学
- 药物开发 药物开发
背景情况:
- 制药行业越来越多地采用新的治疗方式,先进技术和以患者为中心的临床试验设计.
- 癌症药物开发是一个动态的领域,受到科学突破和不断变化的监管框架的影响.
研究的目的:
- 在美国癌症药物开发的背景下,研究创新与监管科学之间的关系.
- 了解监管科学如何适应新兴技术和科学见解.
主要方法:
- 本研究是对当前趋势和实践的审查.
- 分析癌症治疗领域的创新和监管调整之间的相互作用.
主要成果:
- 监管科学不断发展,纳入新的发现,维护安全和监管标准.
- 通过监管适应来推动创新,从而加速开发和改善患者的准入.
- 药物开发商和监管机构之间的早期和一致的沟通至关重要.
结论:
- 创新与监管科学之间的动态相互作用加速了开创性的癌症治疗方法的交付.
- 积极参与监管机构对于成功导航创新药物开发途径至关重要.
- 这种协同作用最终有利于患者,因为它可以更快地获得有前途的新疗法.
相关概念视频
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Drug Discovery: Overview
11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Drug Products: Biologics, Biosimilars and Interchangeables
235
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
235
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Drug Control Governance: Regulatory Bodies and Their Impact
497
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
497


